Tarik Skubal
"A ninth-round pick who nearly lost his arm before it ever threw a big-league pitch, Tarik Skubal became the American League's most dominant starter on his own unhurried timeline."
Skubal was a ninth-round draft pick recovering from Tommy John surgery — the kind of prospect teams stash in the low minors and forget about — and within six years he was the best pitcher in the American League.
Skubal is the centerpiece of a Tigers rebuild that has gone from irrelevant to must-watch, and at under 30 he is signed to the kind of team-friendly extension that makes him the face of Detroit baseball for years, not just a season.
Because he pitches in a small market for a team that spent years near the bottom of the standings, Skubal's 2024 season — leading the AL in ERA, wins, and strikeouts in the same year — got a fraction of the national attention a similar season in New York or Los Angeles would have received.
Hayward, California, where Skubal was born, is not a baseball factory town like Fukuoka or Yokohama producing scouted prodigies from childhood — it's an unremarkable San Francisco Bay Area suburb known mostly for its municipal airport, and Skubal's path through a mid-major college program (Seattle University) followed by a ninth-round draft slot reflects how unglamorous and unpredictable the American amateur pipeline can be compared to Japan's more centralized high school and university scouting culture.
Detroit's difficult decade in the 2010s and early 2020s means most casual fans checked out of the Tigers entirely — so Skubal's ascent to a unanimous-caliber Cy Young season happened almost invisibly to the national audience, a reminder that some of the sport's best individual seasons now unfold in markets people have simply stopped watching.
Tarik Skubal is a left-handed starting pitcher for the Detroit Tigers, born November 20, 1996, in Hayward, California. Drafted in the ninth round in 2018 after Tommy John surgery clouded his college career, he debuted in the pandemic-shortened 2020 season and, by 2024, had developed into the reigning American League Cy Young Award winner — the ace of a rebuilding Detroit rotation.
| Year | Team | G | W–L | ERA | IP | SO | WHIP |
|---|---|---|---|---|---|---|---|
| 2026 | DET | 13 | 5–5 | 3.09 | 75.2 | 89 | 0.95 |
| 2025 | DET | 31 | 13–6 | 2.21 | 195.1 | 241 | 0.89 |
| 2024 | DET | 31 | 18–4 | 2.39 | 192.0 | 228 | 0.92 |
| Career | — | 150 | 59–42 | 3.08 | 842.1 | 978 | 1.02 |
Source: MLB Stats API · regular season
The Long Way Back
Before he was an American League ace, Tarik Skubal was a rehab project. While pitching collegiately at Seattle University, he underwent Tommy John surgery — the elbow ligament reconstruction that has become almost a rite of passage for pitchers, but one that still costs most of them a full year and no shortage of uncertainty about what comes back. The Detroit Tigers selected him in the ninth round of the 2018 draft, a slot reserved for players teams view as worth a flyer rather than a sure thing. Ninth-round picks who've already had major elbow surgery are, by the sport's own math, long shots. Skubal was 6-foot-3, 240 pounds, left-handed, and largely unproven — the kind of file that gets buried in a scouting department's cabinet rather than promoted.
A Debut Without a Crowd
Skubal made his major-league debut on August 18, 2020, in a season unlike any other in the sport's history — no fans in the stands, games played in empty, echoing ballparks because of the pandemic. It was an odd entry point for any player, let alone one still building trust in an elbow that had already betrayed him once. The Tigers of that era were rebuilding from the bottom up, which meant a young pitcher without a finished product could take his lumps in relative obscurity, away from the pressure of contention. That obscurity, in hindsight, may have been a gift.
Named after the pitcher who first underwent it in 1974, Tommy John surgery reconstructs the ulnar collateral ligament in the elbow using a tendon graft. It has become common enough in American baseball — at the high school, college, and professional levels — that pitchers who've had it are no longer viewed as damaged goods, but the recovery timeline (typically 12 to 18 months) still shapes how teams value and draft young arms, as it did with Skubal in 2018.
The Unicorn Season
By 2024, Skubal had assembled one of the more complete pitching seasons in recent American League memory, leading the league in earned run average, wins, and strikeouts in the same year — a rare feat sometimes called a pitching triple crown — and was named the American League's Cy Young Award winner. What made the season notable wasn't just its statistical shape but its context: a Tigers team that had spent years near the bottom of the standings suddenly had, in its own rotation, the best pitcher in its league. For a franchise whose identity for a decade had been rebuilding rather than winning, that was its own kind of milestone.
What Comes Next
Skubal is still in his late twenties, which in pitching terms is closer to the beginning of a prime than the end of one. The trajectory so far — surgery, obscurity, a quiet debut, then a league-leading season — suggests a pitcher who has been more patient with his own development than the sport's usual timelines demand. Whether Detroit can build a contender around him, or whether his individual excellence will again outpace his team's record, is the question that will define the next several Tigers seasons as much as it defines his own.
When American front offices describe a team as 'rebuilding,' it signals a multi-year strategy of accumulating young, cost-controlled talent rather than competing immediately — often accompanied by trading established veterans for prospects. Skubal's entire major-league career to this point has taken place inside that kind of Tigers rebuild, which is part of why his individual excellence has drawn less national attention than it likely would on a team built to win immediately.
Official MLB Shop and Amazon links matched to Tarik Skubal and the Detroit Tigers.
Tarik Skubal gear at the official MLB ShopThis profile was written by AI (Claude Sonnet) using publicly available sources. Interpretations and cultural notes are AI-generated and may not reflect the views of the player, their team, or MLB. This page contains affiliate links.